000 01080 a2200337 4500
005 20250512214825.0
264 0 _c19841017
008 198410s 0 0 eng d
022 _a0722-2211
024 7 _a10.1007/BF02014882
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKatznelson, D
245 0 0 _aFosfomycin in the treatment of cystic fibrosis.
_h[electronic resource]
260 _bEuropean journal of clinical microbiology
_cJun 1984
300 _a213 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aCystic Fibrosis
_xcomplications
650 0 4 _aFemale
650 0 4 _aFosfomycin
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPseudomonas Infections
_xdrug therapy
700 1 _aYahav, Y
700 1 _aRubinstein, E
773 0 _tEuropean journal of clinical microbiology
_gvol. 3
_gno. 3
_gp. 213
856 4 0 _uhttps://doi.org/10.1007/BF02014882
_zAvailable from publisher's website
999 _c6468243
_d6468243